Analysis

Palantir's 40% Surge Ends as AI Backlog Growth Fuels Valuation Debate

Palantir shares ended a 40% weekly rally at $172.01 as Q2 revenue surged 93% and U.S. commercial backlog expanded 153%, pushing valuation to 51x sales.

Daniel Marsh · · · 3 min read · 7 views
Palantir's 40% Surge Ends as AI Backlog Growth Fuels Valuation Debate
Mentioned in this article
BAC $63.17 +0.27% C $135.00 +0.88% DB $38.06 +1.14% JEF $56.62 +0.53% PLTR $172.01 +10.32% RY $211.08 -0.18%

Palantir Technologies (NASDAQ:PLTR) capped a remarkable week on Friday, with shares closing at $172.01, up 10.3% on the day and an eye-popping 39.8% for the week. The surge added roughly $117.6 billion to the company's market capitalization in just five sessions, underscoring the market's enthusiasm for the AI software maker's accelerating growth.

The rally was fueled by a blockbuster second-quarter earnings report that showed revenue climbing 93% year-over-year to $1.94 billion, comfortably beating consensus estimates of $1.81 billion. Adjusted earnings per share of $0.41 came in 18% above expectations. But perhaps more importantly, the value of U.S. commercial contracts expanded by 153% to $2.132 billion, signaling that Palantir's AI platforms are gaining traction beyond pilot programs.

Valuation at the Forefront

With the stock's meteoric rise, Palantir's market value now stands at approximately $413.35 billion, representing a staggering 50.7 times projected 2026 sales and 89.9 times projected adjusted free cash flow. The company raised its 2026 revenue guidance midpoint by nearly $498 million to $8.154 billion, but even that robust upgrade has done little to quell valuation concerns.

Investors are clearly pricing in years of AI-driven cash flow rather than just the current quarter's results. The market cap to guided revenue multiple jumped from 38.6 times to 50.7 times over the week, a 12.1-turn expansion. The equity value increase versus the guidance raise works out to about 236 times, a figure that highlights the market's aggressive re-rating.

Backlog Becomes the Key Metric

Beyond the headline numbers, Palantir's contract backlog may carry even more significance. U.S. commercial total contract value reached $2.132 billion in Q2, up 153% year-over-year, while the remaining deal value stood at $6.238 billion, roughly twice the annualized U.S. commercial revenue for the quarter. This backlog growth suggests strong demand for Palantir's AI offerings, but it also places a premium on execution.

Chief Executive Alex Karp described the quarter as "otherworldly," and industry analysts echoed the sentiment. Emarketer analyst Jacob Bourne called Palantir "the clearest counterexample" to the notion that enterprise AI is failing to move beyond pilot projects. The company's adjusted operating margins, approaching 60%, are expected to be sustained as contracts convert.

U.S. Dominance and Concentration Risk

Palantir's U.S. business accounted for 81.3% of total revenue in Q2, with U.S. commercial revenue up 149% to $764 million and U.S. government revenue up 90% to $809 million. International revenue grew 33% to approximately $363 million, but the heavy reliance on the U.S. market presents both a protective advantage and a concentration risk.

The U.S. commercial segment's remaining deal value of $6.238 billion is particularly encouraging, but any slowdown in U.S. federal spending or commercial adoption could disproportionately impact results. European procurement disputes have also heightened political tensions, potentially complicating international expansion efforts.

Analyst Sentiment Divided

Wall Street remains split on Palantir's fair value. Bank of America's Mariana Perez Mora reiterated a Buy rating with a $255 price target, implying 48.2% upside from Friday's close. Citigroup's Tyler Radke also maintained a Buy with a $245 target, while Deutsche Bank and D.A. Davidson both raised their ratings to Buy with $200 targets.

However, bearish voices remain. Cantor Fitzgerald's Thomas Blakey holds a Neutral stance with a $156 target, while Royal Bank of Canada's Rishi Jaluria and Jefferies' Brent Thill both maintain Sell/Underperform ratings with targets of $90 and $80, respectively. The average analyst price target stands at $197.21, suggesting a modest 14.7% upside from current levels.

Looking Ahead: Inflation Data Looms

With earnings season winding down, attention shifts to macroeconomic data. July consumer price figures are due Wednesday at 8:30 a.m. EDT, with analysts projecting headline inflation at 3.4% and core inflation at 2.5%. Producer price data follows Thursday, and retail sales figures are scheduled for Friday.

An upside surprise in inflation could push Treasury yields higher and weigh on high-multiple technology stocks like Palantir. The company's valuation premium now hinges on sustained execution, with contract conversion needing to outpace the impact of any valuation compression. As one trader noted, the market has priced in perfection, and any stumble could trigger a sharp correction.

This article is for informational purposes only and does not constitute financial advice or a recommendation to buy or sell any security. Market data may be delayed. Always conduct your own research and consult a licensed financial advisor before making investment decisions.

Related Articles

View All →